Drug Type Small molecule drug |
Synonyms KC 706, KC706 |
Target |
Action inhibitors |
Mechanism p38 MAPK inhibitors(P38 mitogen-activated protein kinase inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pemphigus | Phase 2 | United States | 01 Nov 2007 | |
Hyperlipidemias | Phase 2 | Europe | - | - |
Rheumatoid Arthritis | Phase 2 | Europe | - | - |
Psoriasis | Preclinical | United States | - | - |